1. The Roles of Base Modifications in Kidney Cancer
   Chunyue Feng et al, 2020, Frontiers in Oncology CrossRef
2. Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma
   Zhen Zhao et al, 2023, Journal of Molecular Neuroscience CrossRef
3. Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes
   Catarina Guimarães-Teixeira et al, 2021, Journal of Personalized Medicine CrossRef
4. The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
   Yue Shi et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
5. Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
   Ruiliang Wang et al, 2021, Frontiers in Oncology CrossRef
6. Construction of a Prognostic Model for KIRC and Identification of Drugs Sensitive to Therapies - A Comprehensive Biological Analysis Based on m6A-Related LncRNAs
   Dian Xia et al, 2022, Frontiers in Oncology CrossRef
7. Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis
   Linli Xie et al, 2022, Frontiers in Immunology CrossRef
8. m6A-mRNA Methylation Regulates Gene Expression and Programmable m6A Modification of Cellular RNAs With CRISPR-Cas13b in Renal Cell Carcinoma
   Ying Gan et al, 2022, Frontiers in Genetics CrossRef
9. RNA N6‐methyladenosine modifications and potential targeted therapeutic strategies in kidney disease
   Wei‐Jian Ni et al, 2023, British Journal of Pharmacology CrossRef